242 related articles for article (PubMed ID: 16914857)
1. Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease.
Brion JP
J Alzheimers Dis; 2006; 9(3 Suppl):177-85. PubMed ID: 16914857
[TBL] [Abstract][Full Text] [Related]
2. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease.
Endoh R; Ogawara M; Iwatsubo T; Nakano I; Mori H
Brain Res; 1993 Jan; 601(1-2):164-72. PubMed ID: 8431763
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
[TBL] [Abstract][Full Text] [Related]
4. Neurofibrillary tangles and Alzheimer's disease.
Brion JP
Eur Neurol; 1998 Oct; 40(3):130-40. PubMed ID: 9748670
[TBL] [Abstract][Full Text] [Related]
5. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of tau self-aggregation and neurotoxicity.
Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
[TBL] [Abstract][Full Text] [Related]
7. Direct determination of the proportion of intra- and extra-cellular neocortical neurofibrillary tangles in Alzheimer's disease.
Vickers JC; Tan A; Dickson TC
Brain Res; 2003 May; 971(1):135-7. PubMed ID: 12691846
[TBL] [Abstract][Full Text] [Related]
8. Tau protein in Alzheimer’s disease.
Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):607. PubMed ID: 21827396
[No Abstract] [Full Text] [Related]
9. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
[TBL] [Abstract][Full Text] [Related]
10. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation.
Tanabe Y; Ishizu H; Ishiguro K; Itoh N; Terada S; Haraguchi T; Kawai K; Kuroda S
Neuroreport; 2000 Aug; 11(11):2473-7. PubMed ID: 10943706
[TBL] [Abstract][Full Text] [Related]
11. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
12. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
[TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
[TBL] [Abstract][Full Text] [Related]
14. Assembly of filamentous tau aggregates in human neuronal cells.
Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH
J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
[TBL] [Abstract][Full Text] [Related]
16. Tau as a therapeutic target for Alzheimer's disease.
Boutajangout A; Sigurdsson EM; Krishnamurthy PK
Curr Alzheimer Res; 2011 Sep; 8(6):666-77. PubMed ID: 21679154
[TBL] [Abstract][Full Text] [Related]
17. A new kind of Alzheimer's disease plaque.
Baum L; Ng HK
Adv Anat Pathol; 1998 May; 5(3):170-4. PubMed ID: 9868523
[No Abstract] [Full Text] [Related]
18. TDP-43 interacts with pathological τ protein in Alzheimer's disease.
Tomé SO; Gomes LA; Li X; Vandenberghe R; Tousseyn T; Thal DR
Acta Neuropathol; 2021 May; 141(5):795-799. PubMed ID: 33797585
[No Abstract] [Full Text] [Related]
19. Protein studies try to puzzle out Alzheimer's tangles.
Roush W
Science; 1995 Feb; 267(5199):793-4. PubMed ID: 7846523
[No Abstract] [Full Text] [Related]
20. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
Takeda M; Kudo T; Taniguchi N; Nishimura T
Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
